David Baxter PhD
Late Founder
Rolaids Antacid Tablets packaged in bottles recalled due to possible health risks
Health Canada Information Update 2010-08
January 16, 2010
OTTAWA - Health Canada is informing Canadians that Rolaids antacid tablets packaged in bottles of 150 and 100 counts are being voluntarily recalled in Canada by the distributor, McNeil Consumer Healthcare (Canada), Division of Johnson & Johnson Inc. The recall comes in light of reports in the U.S. of an unusual mouldy, musty, or mildew-like odour that was, in some cases, associated with nausea, stomach pain, vomiting and diarrhea.
The distributor has confirmed that the recall does not extend beyond the Rolaids antacid tablets packaged in bottles of 150 and 100 counts. The recalled products are:
Description DIN/NPN UPC (EA) LOT Numbers
The health effects of this chemical have not been well studied. According to the U.S. manufacturer, all of the reactions (e.g. nausea, stomach pain, diarrhea, etc.) reported in the U.S. to date have been temporary and non-serious.
Consumers who have purchased any of the above-listed products and who have concerns about their health should speak to a health care professional. The distributor advises consumers who have purchased bottles of Rolaids antacid tablets to stop using the product and to contact McNeil Consumer Healthcare (Canada) at 1-800-661-4659, Monday-Friday 8a.m. to 8p.m. EST for instructions on how to return or replace the product. Consumers can also visit Johnson & Johnson.
The recall is part of an expansion of an earlier U.S. recall by the manufacturer of certain Tylenol Arthritis products following reports of the same smell and stomach problems. This earlier recall did not affect products sold in Canada. Information on the earlier recall of products in the U.S. can be found in the following Health Canada Foreign Product Alert. Information on the expanded recall of products sold in the U.S. is available on the U.S. Food and Drug Administration website.
Consumers requiring more information about this information update can contact Health Canada?s public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
Health Canada Information Update 2010-08
January 16, 2010
OTTAWA - Health Canada is informing Canadians that Rolaids antacid tablets packaged in bottles of 150 and 100 counts are being voluntarily recalled in Canada by the distributor, McNeil Consumer Healthcare (Canada), Division of Johnson & Johnson Inc. The recall comes in light of reports in the U.S. of an unusual mouldy, musty, or mildew-like odour that was, in some cases, associated with nausea, stomach pain, vomiting and diarrhea.
The distributor has confirmed that the recall does not extend beyond the Rolaids antacid tablets packaged in bottles of 150 and 100 counts. The recalled products are:
Description DIN/NPN UPC (EA) LOT Numbers
- ROLAIDS? Regular Strength Original 150s NPN 02239904 060093200206 AAA526, ACA014, ADA269, AFA052
- ROLAIDS? Regular Strength Spearmint 150s NPN 02239904 060093200213 ABA151, ABA400, ABA401, ABA402, AEA013, ALA257
- ROLAIDS? Extra Strength Freshmint 100s NPN 02240505 060093200237 SSA156, ABA398, SSA236, ADA181, AHA044, AEA198
- ROLAIDS? Extra Strength Mixed Fruit 100s NPN 02240505 060093200244 AAA249, ACA259, AEA196, AFA318, ALA133
- ROLAIDS? Multi-Symptom Berry 100s DIN 02247314 060245200443 ABA535, AHA075
The health effects of this chemical have not been well studied. According to the U.S. manufacturer, all of the reactions (e.g. nausea, stomach pain, diarrhea, etc.) reported in the U.S. to date have been temporary and non-serious.
Consumers who have purchased any of the above-listed products and who have concerns about their health should speak to a health care professional. The distributor advises consumers who have purchased bottles of Rolaids antacid tablets to stop using the product and to contact McNeil Consumer Healthcare (Canada) at 1-800-661-4659, Monday-Friday 8a.m. to 8p.m. EST for instructions on how to return or replace the product. Consumers can also visit Johnson & Johnson.
The recall is part of an expansion of an earlier U.S. recall by the manufacturer of certain Tylenol Arthritis products following reports of the same smell and stomach problems. This earlier recall did not affect products sold in Canada. Information on the earlier recall of products in the U.S. can be found in the following Health Canada Foreign Product Alert. Information on the expanded recall of products sold in the U.S. is available on the U.S. Food and Drug Administration website.
Consumers requiring more information about this information update can contact Health Canada?s public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
